Executive Director, Payer Strategy and Engagement (Tumor HI Program)
rezolutebio· Market Access & Policy
About this role
Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our mission is to bring hope and meaningful solutions to patients and families affected by rare and difficult-to-treat diseases through scientific innovation, collaboration, and integrity.
Rezolute’s lead investigational therapy, RZ358 (ersodetug), is a fully human monoclonal antibody in late-stage clinical development for the treatment of hypoglycemia due to congenital and acquired forms of hyperinsulinism (HI). As Rezolute expands its medical and scientific focus into tumor-related hyperinsulinism (tumor HI), most commonly related to pancreatic neuroendocrine tumors (insulinomas) or paraneoplastic hypoglycemia (NICTH), the company is committed to advancing novel therapeutic strategies that address this rare and complex form of hypoglycemia associated with insulin-secreting tumors and related neuro-oncology disorders.
Frequently Asked Questions
Is the salary disclosed for the Executive Director, Payer Strategy and Engagement (Tumor HI Program) position at rezolutebio?
The salary for this Executive Director, Payer Strategy and Engagement (Tumor HI Program) role at rezolutebio is not publicly listed. Click "Apply Now" to learn more about the compensation package on their official careers page.
Where is the Executive Director, Payer Strategy and Engagement (Tumor HI Program) position at rezolutebio located?
This Executive Director, Payer Strategy and Engagement (Tumor HI Program) role at rezolutebio is based in Redwood City. The position is listed as on-site or hybrid. Check the full job description or apply directly to confirm the work arrangement.
Is the Executive Director, Payer Strategy and Engagement (Tumor HI Program) role at rezolutebio full-time or part-time?
This is listed as a Full Time position. It is posted as a Executive Director, Payer Strategy and Engagement (Tumor HI Program) role in the Market Access & Policy department at rezolutebio.
Which team or department does the Executive Director, Payer Strategy and Engagement (Tumor HI Program) at rezolutebio belong to?
This Executive Director, Payer Strategy and Engagement (Tumor HI Program) position is part of the Market Access & Policy department at rezolutebio. See the full job description for more information about the team structure and responsibilities.
How do I apply for the Executive Director, Payer Strategy and Engagement (Tumor HI Program) position at rezolutebio?
Click the "Apply Now" button on this page. You will be redirected to rezolutebio's official application portal hosted on lever where you can submit your application directly.
When was the Executive Director, Payer Strategy and Engagement (Tumor HI Program) job at rezolutebio posted?
This Executive Director, Payer Strategy and Engagement (Tumor HI Program) position at rezolutebio was posted on Jun 2, 2026. Apply as soon as possible — early applications are often reviewed first.
Executive Director, Payer Strategy and Engagement (Tumor HI Program)
rezolutebio
You'll be redirected to rezolutebio's official application page on Lever.